Vera Therapeutics Statistics

Total Valuation

VERA has a market cap or net worth of $2.17 billion. The enterprise value is $2.06 billion.

Market Cap	2.17B
Enterprise Value	2.06B

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

VERA has 54.92 million shares outstanding. The number of shares has increased by 60.73% in one year.

Shares Outstanding	54.92M
Shares Change (YoY)	+60.73%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	7.95%
Owned by Institutions (%)	85.25%
Float	39.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	21.32
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.71, with a Debt / Equity ratio of 0.53.

Current Ratio	7.71
Quick Ratio	n/a
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.35

Financial Efficiency

Return on equity (ROE) is -73.30% and return on invested capital (ROIC) is -65.65%.

Return on Equity (ROE)	-73.30%
Return on Assets (ROA)	-50.80%
Return on Capital (ROIC)	-65.65%
Revenue Per Employee	n/a
Profits Per Employee	-$1.88M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, VERA has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +516.88% in the last 52 weeks. The beta is 1.05, so VERA's price volatility has been similar to the market average.

Beta (1Y)	1.05
52-Week Price Change	+516.88%
50-Day Moving Average	43.48
200-Day Moving Average	23.10
Relative Strength Index (RSI)	44.71
Average Volume (30 Days)	1,418,493

Short Selling Information

The latest short interest is 6.33 million, so 11.53% of the outstanding shares have been sold short.

Short Interest	6.33M
Short Previous Month	6.24M
Short % of Shares Out	11.53%
Short % of Float	15.87%
Short Ratio (days to cover)	7.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-102.01M
Pretax Income	-95.99M
Net Income	-95.99M
EBITDA	-94.07M
EBIT	-92.20M
Earnings Per Share (EPS)	-$2.25

Full Income Statement

Balance Sheet

The company has $160.72 million in cash and $53.71 million in debt, giving a net cash position of $107.01 million or $1.95 per share.

Cash & Cash Equivalents	160.72M
Total Debt	53.71M
Net Cash	107.01M
Net Cash Per Share	$1.95
Equity / Book Value	101.69M
Book Value Per Share	1.85
Working Capital	149.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$92.18 million and capital expenditures -$63,000, giving a free cash flow of -$92.24 million.

Operating Cash Flow	-92.18M
Capital Expenditures	-63,000
Free Cash Flow	-92.24M
FCF Per Share	-$2.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-60.73%
Shareholder Yield	-60.73%
Earnings Yield	-4.43%
FCF Yield	-4.25%

Dividend Details

Analyst Forecast

The average price target for VERA is $32.29, which is -18.21% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$32.29
Price Target Difference	-18.21%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2